Last updated: 25 June 2024 at 6:06pm EST

Eduardo Rene Salas Net Worth




The estimated Net Worth of Eduardo Rene Salas is at least 117 千$ dollars as of 23 June 2024. Eduardo Salas owns over 1,567 units of Intra-Cellular Therapies Inc stock worth over 117,086$ and over the last 3 years Eduardo sold ITCI stock worth over 0$.

Eduardo Salas ITCI stock SEC Form 4 insiders trading

Eduardo has made over 1 trades of the Intra-Cellular Therapies Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Eduardo exercised 1,567 units of ITCI stock worth 117,086$ on 23 June 2024.

The largest trade Eduardo's ever made was exercising 1,567 units of Intra-Cellular Therapies Inc stock on 23 June 2024 worth over 117,086$. On average, Eduardo trades about 313 units every 0 days since 2022. As of 23 June 2024 Eduardo still owns at least 1,567 units of Intra-Cellular Therapies Inc stock.

You can see the complete history of Eduardo Salas stock trades at the bottom of the page.



What's Eduardo Salas's mailing address?

Eduardo's mailing address filed with the SEC is C/O INTRA-CELLULAR THERAPIES, INC., 430 EAST 29TH STREET, NEW YORK, NY, 10016.

Insiders trading at Intra-Cellular Therapies Inc

Over the last 11 years, insiders at Intra-Cellular Therapies Inc have traded over 77,703,646$ worth of Intra-Cellular Therapies Inc stock and bought 3,068,522 units worth 52,322,638$ . The most active insiders traders include Rory B RiggsJoel S MarcusChristopher D Alafi. On average, Intra-Cellular Therapies Inc executives and independent directors trade stock every 17 days with the average trade being worth of 2,787,280$. The most recent stock trade was executed by Sharon Mates on 29 August 2024, trading 70,000 units of ITCI stock currently worth 891,100$.



What does Intra-Cellular Therapies Inc do?

intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states.



Complete history of Eduardo Salas stock trades at Intra-Cellular Therapies Inc

インサイダー
取引
取引
合計金額
Eduardo Rene Salas
オプション行使 120,001$
23 Jun 2024


Intra-Cellular Therapies Inc executives and stock owners

Intra-Cellular Therapies Inc executives and other stock owners filed with the SEC include: